Abstract
Toxic effects resulting from contrast medium (CM) injections can be considered in two major categories: (a) local and (b) systemic. Local toxicity results from injections of high concentrations and/or quantities of CM into a vessel supplying an organ or tissue. Ultimately, the degree of toxicity must be a function of the concentration and the application time of the injected material. Hence, such factors as organic luminal obstructions, functional obstructions, viscosity changes, and other hemodynamic alterations that prolong the application time increase the chemo toxicity of the injected CM. The precise etiology of chemotoxicity is still poorly understood, but it is thought to involve such factors as molecular interference with functional proteins such as enzymes and regulators and/or hyperosmolarity of the CM solution. Underlying the potential of CM to act as general enzyme inhibitors is their ability to bind to proteins. Such binding appears to reflect principally the degree of hydrophobicity of the CM molecules [1–5]. The correlation between the lethal doses of CM in experimental animals and the binding of CM to serum albumins and various enzymes has been established [6]. In a series of studies, all the CM investigated, if present in sufficiently high concentrations, inhibited the enzymes tested [1–3]. The concentrations and total dosages of CM used in intravascular studies are so high that it is not surprising to find downstream from an intravascular injection a concentration of CM sufficient for a 50% inhibition of a given enzyme system in vitro.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Lang JH, Lasser EC (1971) Nonspecific inhibition of enzymes by organic contrast media. J Med Chem 14:233–236
Lasser EC, Lang JH (1970) Physiologic significance of contrast-protein interactions. I. Study in vitro of some enzyme effects. Invest Radiol 5:514–517
Lang JH, Lasser EC (1975) Inhibition of adenosine triphosphatase and carbonic anhy-drase by contrast media. Invest Radiol 10:314–316
Lasser EC, Lang JH (1970) Contrast-protein interactions. The symposium on contrast media toxicity of the association of University Radiologists, Skytop, May 3–6, 1970. Invest Radiol 5:373–502
Lasser EC, Farr RS, Fujimagari T, Tripp WM (1962) The significance of protein-binding of contrast media in roentgen diagnosis. AJR 87:338–360
Han SY, Sitten DM (1974) Clinical trial of bilopaque oral cholecystography. Evaluation of time of optimal and peak opacification of the gallbladder. Radiology 112:529–531
Simon AL, Shebetai R, Lang JH, Lasser EC (1972) The mechanism of production of ventricular fibrillation in coronary angiography. AJR 114:810–816
Golman K (1979) The blood-brain barrier: effects of nonionic contrast media with and without addition of Ca2 + and Mg2 +. Invest Radiol 14:305–308
Ausman JI, Young R, Owens G (1964) Radio-opaque dyes and other agents in the production of endothelial damage. J Surg Res 4:349–355
Waldron RL, Bridenbaugh RB, Dempsey EW (1974) Effect of angiographic contrast media at the cellular level in the brain: hypertonic vs. chemical action. AJR 122:469–476
Cogen FC, Norman ME, Dunsky E, Hirshfeld J, Zweiman B (1979) Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol 64:200–303
Ring J, Arroyave CM (1979) Alteration of human blood cells and changes in plasma mediators produced by radiographic contrast media. Z Immunitaetsforsch Immunobiol 155:200–211
Ansell G, Tweedie MCK, West CR, Evans P, Couch L (1980) The current status of reactions to intravenous contrast media. Material presented at international contrast material symposium, Colorado Springs, May 1979. Invest Radiol 515:32–39
Lasser EC, Walters AJ, Lang JH (1974) An experimental basis for histamine release in contrast material reactions. Radiology 110:49
Rockoff SD, Brasch R (1971) Contrast media as histamine liberators. III. Histamine release and some associated hemodynamic effects during pulmonary angiography in the dog. Invest Radiol 6:110
Rockoff SD, Brasch R (1972) Contrast media as histamine liberators. V. Comparison of in vitro mast cell histamine release by sodium and methylglucamine salts. Invest Radiol 7:177
Seidel G, Groppe G, Meyer-Burgdorff HC (1974) Contrast media as histamine liberators in man. Agents Actions 4:143
Arroyave CM, Bhat KH, Crown R (1976) Activation of the alternative pathway of the complement system by radiographic contrast media. J Immunol 117:1866
Siegle RL, Lieberman P (1976) Measurement of histamine, complement components and immune complexes during patient reactions to iodinated contrast material. Invest Radiol 11:98–101
Ring J, Arroyave CM, Fritzler MJ, Tan EM (1978) In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 32:105–118
Ring J, Endrich B, Intaglietta M (1978) Histamine release, complement consumption and microvascular changes after radiographic contrast media infusion in rabbits. J Lab Clin Med 92:584
Arroyave CM (1980) An in vitro assay for radiographic contrast media idiosyncrasy. Presented at international contrast material symposium, Colorado Springs, May 1979. Invest Radiol 15:21–25
Brasch R, Caldwell JL, Fudenberg HH (1976) Antibodies to radiographic contrast agents. Induction and characterization of rabbit antibody. Invest Radiol 2:1–9
Brasch RC, Caldwell JL (1976) The allergic theory of radiocontrast agent toxicity: demonstration of antibody activity and sera of patients suffering major radiocontrast agent reactions. Invest Radiol 2:347–356
Brasch RC (1980) Allergic reactions to contrast media: accumulated evidence. AJR 134:797–801
Wakkers-Garritsen BG, Houwerziji J, Nater JP, Wakkers PJM (1976) IgE-mediated adverse reactivity to a radiographic contrast medium — case report. Ann Allergy 36:122–126
Lalli AF (1974) Urographic contrast media reactions and anxiety. Radiology 112:267–271
Lasser EC, Sovak M, Lang JH (1976) Development of contrast media idiosyncrasy in the dog. Radiology 119:91–95
Kolb WP, Lang JH, Lasser EC (1978) Nonimmunologic complement activation in normal human serum induced by X-ray contrast media. J Immunol 121:1232–1238
Till G, Rother U, Gemsa D (1978) Activation of complement by radiographic contrast media. Int Arch Allergy Appl Imunol 56:543–550
Arroyave CM, Bhat K, Crown R (1976) Activation of serum complement by contrast media. J Immunol 117:866–869
Lang JH, Lasser EC, Kolb WP (1976) Activation of the complement system by X-ray contrast media. Invest Radiol 11:303–308
Lasser EC, Lang JH, Sovak M, Kolb WP, Lyon SG, Hamblin AE (1977) Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactions. Radiology 125:1–9
Lasser EC, Slivka J, Lang JH, Kolb WP, Lyon SG, Hamblin AE, Nazareno G (1979) Complement and coagulation — causative considerations in contrast catastrophes. AJR 132:171–176
Lasser EC, Lang JH, Lyon SG, Hamblin AE (1979) Complement and contrast material reactors. J Allergy Clin Immunol 64:102–112
Lasser EC, Lang JH, Lyon SG, Hamblin AE (1980) Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis. Presented at international contrast material symposium, Colorado Springs, May 1979. Invest Radiol 15:6–12
Zeman RK (1977) Disseminated intravascular coagulation following intravenous pyelography. (letter) Invest Radiol 12:203–204
Wieners H (1977) Klinisch-immunologische Probleme bei der Kontrastmittelanwendung bei Gammapathien und Erkrankungen des rheumatischen Formenkreises. Symposium on adverse reactions to contrast media, Schering, Berlin, pp 67–69
Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard MM (1981) Glucocorticoid-induced elevations of CI-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits. Invest Radiol 16:20–23
Osterud B (1979) The role of endothelial cells and subendothelial components in the initiation of blood coagulation. Haemostasis 8:324–331
Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard MM (1981) Prekallikrein-kallikrein conversion: conversion rates as a predictor for contrast catastrophes. Radiology 140:11–15
Yocum NW, Heller AM, Abels RI (1978) Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients. J Allergy Clin Immunol 62:309–313
Shehadi WN (1975) Adverse reactions to intravascularly administered contrast media: a comprehensive study based on a prospective study. AJR 124:145–152
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lasser, E.C. (1984). Adverse Systemic Reactions to Contrast Media. In: Sovak, M. (eds) Radiocontrast Agents. Handbook of Experimental Pharmacology, vol 73. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69515-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-69515-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69517-9
Online ISBN: 978-3-642-69515-5
eBook Packages: Springer Book Archive